BCR and neoplasm: Keratinocytes from tissue samples with higher BCR clonotype diversity were skewed toward terminal differentiation compared to those from low BCR clonotype diversity samples, suggesting lower tumor cell presence in these samples despite being biopsied from the center of clinically active disease.